FIELD: medicine.
SUBSTANCE: invention relates to cardiology. Disclosed is the use of polyprenols of formula (1) as an active ingredient of a pharmaceutical composition for treating anxiety and depression in patients with acute myocardial infarction.
EFFECT: use of polyprenols in the pharmaceutical composition enables effective reduction of the general level of anxiety and depression with minimal negative effect on the body of patients suffering acute myocardial infarction.
1 cl, 3 tbl, 3 ex
где - where
Authors
Dates
2019-12-05—Published
2019-08-08—Filed